Ebola vaccine trial approved in Switzerland

Listen /

Ebola vaccines. Photo: WHO/M. Missioneiro

The trial of an experimental Ebola vaccine at Lausanne University Hospital in Switzerland has been approved by a Swiss agency that supervises health products.

The World Health Organization (WHO) says the trial will test the safety of the vaccine and its capacity to induce an immune response.

Scheduled to begin this week, it is the second trial coordinated by WHO in Switzerland.

Tarik Jasarevic is a WHO spokesperson.

“This approval means that approximately 120 individuals in Lauzanne will be used to trial this vaccine as volunteers. The trial is also ongoing in Mali, the United Kingdom and the United States.”

Mr Jasarevic explained that the vaccine is based on a genetically modified chimpanzee virus.

WHO says the results of the trial, expected in December, will provide the basis for planning subsequent trials involving several thousand participants.

Stephanie Coutrix, United Nations.

Duration: 1’01″

UN Radio Daily News Programme
UN Radio Daily News Programme
Updated at 1800 GMT, Monday to Friday
Loading the player ...

CONNECT

 

October 2017
M T W T F S S
« Sep    
 1
2345678
9101112131415
16171819202122
23242526272829
3031